Market Tracker

04/24 6:02pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

16.86
Delayed Data
As of Apr 24
 -0.085 / -0.50%
Today’s Change
6.88
Today|||52-Week Range
17.27
+74.72%
Year-to-Date

Today’s Trading

Previous close16.95
Today’s open17.00
Day’s range16.53 - 17.27
Volume1,408,188
Average volume (3 months)1,422,280
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+10.25%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book51.26

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-0.07-0.81%
ESPREsperion Therapeutic...-4.29-3.94%
OPHTOphthotech Corp+0.17+0.33%
KITEKite Pharma Inc-0.35-0.57%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts